To view this email as a web page, click here

Dear E,

You're invited to the Fierce Biotech Virtual Event: From growing cells to growing pains: Navigating new obstacles in cell & gene therapy.

As the gene therapy revolution starts coming to fruition, new challenges are emerging. Scaling up manufacturing at a time when hundreds of therapies are advancing has strained capacity and created shortages in the supply chain. Recent FDA actions are raising questions about its regulatory requirements. And all the usual hurdles to developing and launching new treatments still apply.

Join Fierce Biotech October 19th for a one-day virtual event to learn how companies are navigating manufacturing, regulatory requirements and scientific breakthroughs—and what’s being done industry-wide to smooth the path to market.

I hope you can join us. Click here to reserve your seat today.

Rebecca Willumson
Publisher
Fierce Biotech & Fierce Pharma
rwillumson@questex.com

 

 

You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.

Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2021 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.